# To Evaluate the Efficacy and Safety of MaxioCel Versus Aquacel Extra for the Management of Chronic Wounds

> **NCT05312762** · NA · UNKNOWN · sponsor: **Axio Biosolutions Pvt. Ltd.** · enrollment: 118 (estimated)

## Conditions studied

- Wound

## Interventions

- **DEVICE:** MaxioCel
- **DEVICE:** AquaCel Extra

## Key facts

- **NCT ID:** NCT05312762
- **Lead sponsor:** Axio Biosolutions Pvt. Ltd.
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-04-27
- **Primary completion:** 2023-12-11
- **Final completion:** 2023-12-31
- **Target enrollment:** 118 (ESTIMATED)
- **Last updated:** 2023-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05312762

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05312762, "To Evaluate the Efficacy and Safety of MaxioCel Versus Aquacel Extra for the Management of Chronic Wounds". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05312762. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*